part_subject: "GOOD LABORATORY PRACTICE FOR NONCLINICAL LABORATORY STUDIES"
subpart_code: "B"
subpart_subject: "Organization and Personnel"
section_number: "58.31"
section_subject: "Testing facility management."
cfr_reference: "21 CFR 58.31"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 1 to 99"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
For each nonclinical laboratory study, testing facility management shall:
(a)Designate a study director as described in § 58.33, before the study is initiated.
(b)Replace the study director promptly if it becomes necessary to do so during the conduct of a study.
(c)Assure that there is a quality assurance unit as described in § 58.35.
(d)Assure that test and control articles or mixtures have been appropriately tested for identity, strength, purity, stability, and uniformity, as applicable.
(e)Assure that personnel, resources, facilities, equipment, materials, and methodologies are available as scheduled.
(f)Assure that personnel clearly understand the functions they are to perform.
(g)Assure that any deviations from these regulations reported by the quality assurance unit are communicated to the study director and corrective actions are taken and documented.